Home » Analyst Articles – US

Donaldson (NYSE:DCI) Cut to “Hold” at Wall Street Zen

Donaldson (NYSE:DCI) Cut to “Hold” at Wall Street Zen

Donaldson (NYSE:DCI – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Sunday. Several other equities... More of this article »
RCM Technologies (NASDAQ:RCMT) Stock Rating Upgraded by Wall Street Zen

RCM Technologies (NASDAQ:RCMT) Stock Rating Upgraded by Wall Street Zen

RCM Technologies (NASDAQ:RCMT – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a note issued to investors on Sunday. Several other equities... More of this article »
Oaktree Specialty Lending (NASDAQ:OCSL) Downgraded to “Sell” Rating by Wall Street Zen

Oaktree Specialty Lending (NASDAQ:OCSL) Downgraded to “Sell” Rating by Wall Street Zen

Oaktree Specialty Lending (NASDAQ:OCSL – Get Free Report) was downgraded by Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Sunday. A number of other research analysts have... More of this article »
SunCar Technology Group (NASDAQ:SDA) Upgraded to “Buy” at Wall Street Zen

SunCar Technology Group (NASDAQ:SDA) Upgraded to “Buy” at Wall Street Zen

SunCar Technology Group (NASDAQ:SDA – Get Free Report) was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a note issued to investors on Sunday. A number of other brokerages... More of this article »
Wall Street Zen Upgrades La-Z-Boy (NYSE:LZB) to Buy

Wall Street Zen Upgrades La-Z-Boy (NYSE:LZB) to Buy

La-Z-Boy (NYSE:LZB – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Sunday. Separately, Weiss Ratings... More of this article »
Viridian Therapeutics (NASDAQ:VRDN) Upgraded by Wall Street Zen to Sell Rating

Viridian Therapeutics (NASDAQ:VRDN) Upgraded by Wall Street Zen to Sell Rating

Viridian Therapeutics (NASDAQ:VRDN – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “strong sell” rating to a “sell” rating in a research note issued to investors... More of this article »
JPMorgan Chase & Co. Issues Positive Forecast for Morgan Stanley (NYSE:MS) Stock Price

JPMorgan Chase & Co. Issues Positive Forecast for Morgan Stanley (NYSE:MS) Stock Price

Morgan Stanley (NYSE:MS – Free Report) had its price target boosted by JPMorgan Chase & Co. from $179.00 to $187.00 in a research report sent to investors on Friday, Marketbeat.com reports. They currently have a neutral... More of this article »
Adobe (NASDAQ:ADBE) Price Target Cut to $228.00 by Analysts at Citigroup

Adobe (NASDAQ:ADBE) Price Target Cut to $228.00 by Analysts at Citigroup

Adobe (NASDAQ:ADBE – Free Report) had its price target trimmed by Citigroup from $264.00 to $228.00 in a report issued on Friday morning,Benzinga reports. The brokerage currently has a neutral rating on the software company’s... More of this article »
The Goldman Sachs Group (NYSE:GS) Given New $900.00 Price Target at JPMorgan Chase & Co.

The Goldman Sachs Group (NYSE:GS) Given New $900.00 Price Target at JPMorgan Chase & Co.

The Goldman Sachs Group (NYSE:GS – Free Report) had its target price lifted by JPMorgan Chase & Co. from $826.00 to $900.00 in a research note published on Friday, MarketBeat Ratings reports. JPMorgan Chase & Co. currently... More of this article »
Adobe (NASDAQ:ADBE) Given New $340.00 Price Target at JPMorgan Chase & Co.

Adobe (NASDAQ:ADBE) Given New $340.00 Price Target at JPMorgan Chase & Co.

Adobe (NASDAQ:ADBE – Free Report) had its target price cut by JPMorgan Chase & Co. from $420.00 to $340.00 in a research report sent to investors on Friday,Benzinga reports. They currently have an overweight rating on the... More of this article »
Adobe (NASDAQ:ADBE) Price Target Cut to $225.00 by Analysts at UBS Group

Adobe (NASDAQ:ADBE) Price Target Cut to $225.00 by Analysts at UBS Group

Adobe (NASDAQ:ADBE – Free Report) had its price objective decreased by UBS Group from $260.00 to $225.00 in a research note published on Friday, Marketbeat Ratings reports. UBS Group currently has a neutral rating on the software... More of this article »
RMG ML Sports (NASDAQ:SHOTU) Upgraded to Hold at Wall Street Zen

RMG ML Sports (NASDAQ:SHOTU) Upgraded to Hold at Wall Street Zen

RMG ML Sports (NASDAQ:SHOTU – Get Free Report) was upgraded by equities researchers at Wall Street Zen to a “hold” rating in a report issued on Saturday. RMG ML Sports Price Performance Shares of RMG ML Sports stock... More of this article »
Intuitive Surgical (NASDAQ:ISRG) Price Target Lowered to $515.00 at BofA

Intuitive Surgical (NASDAQ:ISRG) Price Target Lowered to $515.00 at BofA

Intuitive Surgical (NASDAQ:ISRG – Free Report) had its price objective trimmed by BofA from $520.00 to $515.00 in a report published on Friday,MarketScreener reports. A number of other brokerages also recently issued reports... More of this article »
Marvell Technology (NASDAQ:MRVL) Receives “Buy” Rating from Rosenblatt Securities

Marvell Technology (NASDAQ:MRVL) Receives “Buy” Rating from Rosenblatt Securities

Rosenblatt Securities reiterated their buy rating on shares of Marvell Technology (NASDAQ:MRVL – Free Report) in a report issued on Friday,Benzinga reports. Rosenblatt Securities currently has a $240.00 price target on the semiconductor... More of this article »
JPMorgan Chase & Co. Issues Positive Forecast for Tapestry (NYSE:TPR) Stock Price

JPMorgan Chase & Co. Issues Positive Forecast for Tapestry (NYSE:TPR) Stock Price

Tapestry (NYSE:TPR – Free Report) had its target price increased by JPMorgan Chase & Co. from $200.00 to $205.00 in a research report released on Friday morning,Benzinga reports. The brokerage currently has an overweight... More of this article »
Freeport-McMoRan (NYSE:FCX) Given New $75.00 Price Target at HSBC

Freeport-McMoRan (NYSE:FCX) Given New $75.00 Price Target at HSBC

Freeport-McMoRan (NYSE:FCX – Free Report) had its price objective increased by HSBC from $72.00 to $75.00 in a report issued on Friday morning,MarketScreener reports. Several other equities research analysts also recently issued... More of this article »
Valero Energy (NYSE:VLO) Given New $255.00 Price Target at Morgan Stanley

Valero Energy (NYSE:VLO) Given New $255.00 Price Target at Morgan Stanley

Valero Energy (NYSE:VLO – Free Report) had its price target boosted by Morgan Stanley from $232.00 to $255.00 in a research report sent to investors on Friday,Benzinga reports. They currently have an equal weight rating on the... More of this article »
The Hartford Insurance Group (NYSE:HIG) Price Target Lowered to $155.00 at Barclays

The Hartford Insurance Group (NYSE:HIG) Price Target Lowered to $155.00 at Barclays

The Hartford Insurance Group (NYSE:HIG – Free Report) had its price objective decreased by Barclays from $156.00 to $155.00 in a research note published on Friday,Benzinga reports. Barclays currently has an overweight rating... More of this article »
Science Applications International (NASDAQ:SAIC) Given New $96.00 Price Target at The Goldman Sachs Group

Science Applications International (NASDAQ:SAIC) Given New $96.00 Price Target at The Goldman Sachs Group

Science Applications International (NASDAQ:SAIC – Free Report) had its target price lifted by The Goldman Sachs Group from $85.00 to $96.00 in a research report sent to investors on Friday,Benzinga reports. The Goldman Sachs... More of this article »
JPMorgan Chase & Co. Issues Positive Forecast for Nokia (NYSE:NOK) Stock Price

JPMorgan Chase & Co. Issues Positive Forecast for Nokia (NYSE:NOK) Stock Price

Nokia (NYSE:NOK – Free Report) had its price target upped by JPMorgan Chase & Co. from $14.00 to $21.00 in a research note released on Friday morning,Benzinga reports. The brokerage currently has an overweight rating on... More of this article »
Climb Bio (NASDAQ:CLYM) Given “Outperform” Rating at Wedbush

Climb Bio (NASDAQ:CLYM) Given “Outperform” Rating at Wedbush

Wedbush reiterated their outperform rating on shares of Climb Bio (NASDAQ:CLYM – Free Report) in a research note published on Friday morning,Benzinga reports. Wedbush currently has a $17.00 target price on the stock. Other analysts... More of this article »
Molson Coors Beverage (NYSE:TAP) Price Target Lowered to $41.00 at Jefferies Financial Group

Molson Coors Beverage (NYSE:TAP) Price Target Lowered to $41.00 at Jefferies Financial Group

Molson Coors Beverage (NYSE:TAP – Free Report) had its price objective decreased by Jefferies Financial Group from $43.00 to $41.00 in a research note published on Friday,MarketScreener reports. A number of other brokerages have... More of this article »
Hyperliquid Strategies (NASDAQ:PURR) Given “Buy” Rating at Chardan Capital

Hyperliquid Strategies (NASDAQ:PURR) Given “Buy” Rating at Chardan Capital

Chardan Capital reiterated their buy rating on shares of Hyperliquid Strategies (NASDAQ:PURR – Free Report) in a report released on Friday,Benzinga reports. They currently have a $9.75 price objective on the stock. Several other... More of this article »
Coya Therapeutics (NASDAQ:COYA) Receives “Buy” Rating from Chardan Capital

Coya Therapeutics (NASDAQ:COYA) Receives “Buy” Rating from Chardan Capital

Chardan Capital reaffirmed their buy rating on shares of Coya Therapeutics (NASDAQ:COYA – Free Report) in a research note published on Friday,Benzinga reports. They currently have a $14.00 price target on the stock. Several... More of this article »
Truist Financial Issues Positive Forecast for Albany International (NYSE:AIN) Stock Price

Truist Financial Issues Positive Forecast for Albany International (NYSE:AIN) Stock Price

Albany International (NYSE:AIN – Free Report) had its price target raised by Truist Financial from $55.00 to $61.00 in a report published on Friday, Marketbeat.com reports. Truist Financial currently has a hold rating on the... More of this article »